Embracing clinical value in traditional Chinese medicine development

Conflict of interest statement

The authors declare no conflict of interest.

Funding

None.

Author contributions

Xiaoxiao Zhang, Yao Lu, Yong Zhu, Wei Hou, Mingjun Zhu, Xudong Tang, Lei Xiong, Quan Jiang, Xianyu Zeng, Haisong Li, Ruihua Zhao, Yuqiao Lu, Xiaonghong He, and Guochen Wang participated in the writing of the original draft. Xiaoxiao Zhang and Yao Lu participated in review and editing of the paper. Guochen Wang participated in the conceptualization.

Ethical approval of studies and informed consent

Not applicable.

Acknowledgments

None.

Data availability

Not applicable.

References

[1] Zhang X, Lu Y, Hou W, et al.Clinical demand checklist for research and development of new drugs of traditional Chinese medicine(first batch). J Tradit Chin Med. 2024;65(1):17-25.

[2] Wu J, Zhang F, Li Z, et al. Integration strategy of network pharmacology in traditional Chinese medicine: a narrative review. [J] Tradit Chin Med. 2022;42(3):479-486.

RIGHTS & PERMISSIONS

Acupuncture and Herbal Medicine